Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs BIB overlap: 44% of top holdings shared

Bottom line

How much do IBB and BIB overlap?

44% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 47.9% of IBB's assets and 27.2% of BIB's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

IBBBIB
Weight overlap (top 25)44%
Shared holdings12
Weight in shared holdings47.9%27.2%
Total positions254267
Expense ratio0.44%0.95%
Holdings as ofSep 30, 2025May 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Holdings IBB and BIB have in common

Holding% of IBB% of BIBOverlap
Vertex Pharmaceuticals, Inc.7.66%4.65%4.65%
Gilead Sciences, Inc.7.52%4.66%4.66%
Amgen, Inc.7.50%4.48%4.48%
Regeneron Pharmaceuticals, Inc.5.70%3.21%3.21%
Alnylam Pharmaceuticals, Inc.5.68%2.01%2.01%
Argenx SE3.15%1.19%1.19%
Insmed, Inc.2.95%1.16%1.16%
Biogen, Inc.2.03%1.44%1.44%
United Therapeutics Corp.1.82%1.22%1.22%
Incyte Corp.1.62%0.97%0.97%
Illumina, Inc.1.41%1.25%1.25%
Moderna, Inc.0.88%0.94%0.88%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. IQVIA Holdings, Inc. — 3.18%
  3. Mettler-Toledo International, Inc. — 2.49%
  4. Natera, Inc. — 2.11%
  5. BeOne Medicines Ltd. — 2.11%
  6. Waters Corp. — 1.77%
  7. Genmab A/S — 1.38%
  8. Neurocrine Biosciences, Inc. — 1.34%
  9. Medpace Holdings, Inc. — 1.16%
  10. Exelixis, Inc. — 1.07%
  11. Ionis Pharmaceuticals, Inc. — 1.03%
  12. BioMarin Pharmaceutical, Inc. — 1.02%
  13. Madrigal Pharmaceuticals, Inc. — 0.92%

Only in BIB

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. N/a — 3.94%
  4. N/a — 3.26%
  5. N/a — 2.62%
  6. Revolution Medicines, Inc. — 1.57%
  7. Repurchase Agreement — 1.28%
  8. Royalty Pharma plc — 1.20%
  9. N/a — 1.18%
  10. Roivant Sciences Ltd. — 1.08%
  11. Viatris, Inc. — 0.94%
  12. Guardant Health, Inc. — 0.85%
  13. Invesco Govt And Agcy Lex — 0.81%

Asset mix

Asset typeIBBBIB
Stocks99.8%63.0%
Equity derivatives—16.0%
Cash & short-term funds13.4%0.8%
Other—6.8%
Repurchase agreements—3.1%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Country mix

CountryIBBBIB
US98.6%79.8%
NL4.3%1.6%
CH2.7%0.8%
DK2.2%0.8%
GB1.0%1.7%
IE0.5%1.2%
BM0.7%1.1%
FR—1.0%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Check another pair

FAQ

How much do IBB and BIB overlap?
About 44% by weight. 12 securities appear in both funds' top 25 holdings; they make up 47.9% of IBB's assets and 27.2% of BIB's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBB and BIB have in common?
The largest shared holdings are Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc..
Should I own both IBB and BIB?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBB or BIB?
BIB is broader, with 267 positions versus 254 for IBB. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.